Using Chromatin Accessibility to Delineate Therapeutic Subtypes in Pancreatic Cancer Patient-Derived Cell Lines
Summary: Disrupted chromatin regulatory processes contribute to the development of cancer, in particular pancreatic ductal adenocarcinoma. The assay for transposase accessible chromatin with high-throughput sequencing (ATAC-seq) is typically used to study chromatin organization. Here, we present a r...
Main Authors: | Holly Brunton, Ian M. Garner, Ulla-Maja Bailey, Rosie Upstill-Goddard, Peter J. Bailey |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | STAR Protocols |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666166720300666 |
Similar Items
-
FAK regulates IL-33 expression by controlling chromatin accessibility at c-Jun motifs
by: Billie G. C. Griffith, et al.
Published: (2021-01-01) -
Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic Cancer
by: Agnieszka K. Witkiewicz, et al.
Published: (2016-08-01) -
Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic Cancer.
by: Witkiewicz, Agnieszka K, et al.
Published: (2016) -
Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic Cancer
by: Witkiewicz, Agnieszka K., et al.
Published: (2016) -
Delineating conditions and subtypes in chronic pain using neuroimaging
by: Scott A. Holmes, et al.
Published: (2019-08-01)